# Dronabinol As an Adjunct for Reducing Pain (DARP)-Texas Children's Hospital

> **NCT06834997** · PHASE2 · WITHDRAWN · sponsor: **Baylor College of Medicine**

## Conditions studied

- Endometriosis
- Endometriosis Related Pain
- Endometriosis, Pain

## Interventions

- **DRUG:** Dronabinol Capsules
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06834997
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2026-04-01
- **Primary completion:** 2028-03-01
- **Final completion:** 2028-12-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Due to an ongoing national shortage of dronabinol, the study is being discontinued. Given the inability to ensure consistent medication availability, continuation of the study would compromise protocol integrity and participant safety.
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06834997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06834997, "Dronabinol As an Adjunct for Reducing Pain (DARP)-Texas Children's Hospital". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06834997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*